Allianz SE Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Allianz SE bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,380 shares of the company's stock, valued at approximately $1,009,000.

Several other hedge funds have also recently made changes to their positions in the business. Whipplewood Advisors LLC acquired a new position in HCA Healthcare during the 4th quarter valued at about $31,000. Tidemark LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $36,000. Legacy Investment Solutions LLC bought a new position in HCA Healthcare in the 3rd quarter valued at $39,000. Activest Wealth Management grew its position in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after buying an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. lifted its stake in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Up 0.5 %

HCA traded up $1.75 during midday trading on Wednesday, reaching $347.48. The company's stock had a trading volume of 1,249,318 shares, compared to its average volume of 1,347,916. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock's 50-day moving average is $325.79 and its 200-day moving average is $340.25. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm has a market capitalization of $85.55 billion, a price-to-earnings ratio of 15.82, a PEG ratio of 1.10 and a beta of 1.68.

Remove Ads

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company earned $5.90 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a $0.72 dividend. The ex-dividend date of this dividend was Monday, March 17th. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.83%. HCA Healthcare's dividend payout ratio is 13.11%.

Insiders Place Their Bets

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.30% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on HCA shares. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. KeyCorp dropped their price objective on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. Truist Financial decreased their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Morgan Stanley reduced their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 17th. Finally, Bank of America lowered their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.